These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27389665)

  • 1. Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.
    Dalbeth N; Choi HK; Terkeltaub R
    Arthritis Rheumatol; 2017 Jan; 69(1):22-34. PubMed ID: 27389665
    [No Abstract]   [Full Text] [Related]  

  • 2. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.
    Kamatani N; Hosoya T
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264
    [No Abstract]   [Full Text] [Related]  

  • 3. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 4. Why better treatment of gout is needed.
    So AK
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febuxostat : a viewpoint by Naomi Schlesinger.
    Schlesinger N
    Drugs; 2008; 68(13):1875-6. PubMed ID: 18729539
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical revision of the medical treatment of gout in Brazil.
    Azevedo VF; Lopes MP; Catholino NM; Paiva EDS; Araújo VA; Pinheiro GDRC
    Rev Bras Reumatol Engl Ed; 2017; 57(4):346-355. PubMed ID: 28743362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febuxostat: a viewpoint by H. Ralph Schumacher Jr and Lan X. Chen.
    Schumacher HR; Chen LX
    Drugs; 2008; 68(13):1875-6. PubMed ID: 18729538
    [No Abstract]   [Full Text] [Related]  

  • 8. How PCP education can impact gout management: the gout essentials.
    Weaver AL; Cheh MA; Kennison RH
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S42-6. PubMed ID: 18830090
    [No Abstract]   [Full Text] [Related]  

  • 9. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
    Lioté F
    Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
    [No Abstract]   [Full Text] [Related]  

  • 10. Febuxostat : a viewpoint by N. Lawrence Edwards.
    Edwards NL
    Drugs; 2008; 68(13):1875-6. PubMed ID: 18729540
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on gout 2012.
    So A; Busso N
    Joint Bone Spine; 2012 Dec; 79(6):539-43. PubMed ID: 23165182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of urate-lowering therapies: managing the risks to gain the benefits.
    Keenan RT
    Rheum Dis Clin North Am; 2012 Nov; 38(4):663-80. PubMed ID: 23137576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical images: three-dimensional computed tomography imaging of tophaceous gout.
    Dalbeth N; Clark B; Gregory K; Sheehan T; McQueen F
    Arthritis Rheum; 2007 Jan; 56(1):29. PubMed ID: 17195196
    [No Abstract]   [Full Text] [Related]  

  • 15. Gout treatment: should we aim for rapid crystal dissolution?
    Pascual E; Andrés M; Vela P
    Ann Rheum Dis; 2013 May; 72(5):635-7. PubMed ID: 23322814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenges of managing gout in primary care: Results of a best-practice audit.
    Stamp LK; Chapman P; Hudson B; Frampton C; Hamilton G; Judd A
    Aust J Gen Pract; 2019 Sep; 48(9):631-637. PubMed ID: 31476837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.
    Keenan RT
    Clin Ther; 2017 Feb; 39(2):430-441. PubMed ID: 28089200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
    Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
    Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future therapies for gout.
    Pascart T; Richette P
    Expert Opin Pharmacother; 2017 Aug; 18(12):1201-1211. PubMed ID: 28689430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.